Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Colorcon
McKesson
Merck
Johnson and Johnson

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Fluoxetine hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for fluoxetine hydrochloride and what is the scope of patent protection?

Fluoxetine hydrochloride is the generic ingredient in eight branded drugs marketed by Barr, Dr Reddys Labs Ltd, Lilly, Sun Pharm Industries, Watson Labs, Alembic Pharms Ltd, Ani Pharms Inc, Apnar Pharma Lp, Aurobindo Pharma, Beximco Pharms Usa, Cadila Pharms Ltd, Carlsbad, Celltrion, Cr Double Crane, Heritage Pharms Inc, Ivax Sub Teva Pharms, Landela Pharm, Marksans Pharma, Mylan, Mylan Pharms Inc, Par Pharm, Sandoz, Sciegen Pharms Inc, Specgx Llc, Sun Pharm Inds Ltd, Teva, Teva Pharms Usa, Eli Lilly And Co, Actavis Mid Atlantic, Aurobindo Pharma Ltd, Hi Tech Pharma, Lannett Co Inc, Nostrum Labs Inc, Pharm Assoc, Wockhardt Bio Ag, Alvogen, Fosun Pharma, G And W Labs Inc, Inventia Hlthcare, Lupin Ltd, Par Form, Par Pharm Inc, Taro, Torrent, Upsher Smith Labs, Apil, and Teva Pharms, and is included in seventy-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for fluoxetine hydrochloride. Sixty-nine suppliers are listed for this compound. There is one tentative approval for this compound.

Recent Clinical Trials for fluoxetine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineN/A
Huadong HospitalN/A
Yale UniversityPhase 1

See all fluoxetine hydrochloride clinical trials

Recent Litigation for fluoxetine hydrochloride

Identify potential future generic entrants

District Court Litigation
Case NameDate
SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC.2017-07-06
Teva Women's Health, Inc. v. Famy Care Ltd.2014-12-05
Hawthorne v. Eli Lilly And Company2011-12-07

See all fluoxetine hydrochloride litigation

Generic filers with tentative approvals for FLUOXETINE HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
  Start Trial  Start TrialEQ 40MG BASECAPSULE;ORAL
  Start Trial  Start TrialEQ 20MG BASECAPSULE;ORAL
  Start Trial  Start TrialEQ 10MG BASECAPSULE;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for fluoxetine hydrochloride
Medical Subject Heading (MeSH) Categories for fluoxetine hydrochloride
Synonyms for fluoxetine hydrochloride
(+-)-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine hydrochloride
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine, hydrochloride
(+-)-N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propylamine hydrochloride
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine, HCl
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride
(S)-N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine
100568-02-3
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine hydrochloride
54910-89-3 (Parent)
56296-78-7
59333-67-4
910F893
AB04860
AB2000053
AC-1697
AC1L1XXD
Adofen
Affectine
AKOS015894939
Alental
Alzac 20
AN-14688
AN-40216
ANW-42507
Apo-Fluoxentine
BC208532
BCP19962
Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, hydrochloride
Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, hydrochloride, (+-)-
Bioxetin
C17H18F3NO.HCl
CAS-56296-78-7
CCG-39084
CCRIS 6150
CHEMBL1201082
CPD000058452
Cramin
CS-1838
CTK8B3427
D00823
Depreks
Deproxin
Digassim
dl-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine, HCl
DSSTox_CID_635
DSSTox_GSID_20635
DSSTox_RID_75706
DTXSID7020635
EINECS 260-101-2
Equilibrane
Erocap
EU-0100558
F-132
F0750
Felicium
Fluctin
Fluctine
Fludac
Fludeka
Flufran
Fluneurin
Flunil
Flunirin
Fluox-Puren
Fluoxac
Fluoxeren
Fluoxetin HCl
Fluoxetine HCl
Fluoxetine (hydrochloride)
Fluoxetine Hcl
Fluoxetine hydrochloride (JAN/USP)
Fluoxetine hydrochloride [USAN:USP]
Fluoxetine hydrochloride [USAN]
Fluoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Fluoxetine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Fluoxetine hydrochloride, British Pharmacopoeia (BP) Reference Standard
Fluoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Fluoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Fluoxetine hydrochloride, solid
Fluoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Fluoxetine hydrochloride, VETRANAL(TM), analytical standard
Fluoxetine hydrochoride
Fluoxetine, HCl
Fluoxetine, Hydrochloride
Fluoxetine.HCl
FluoxetineHydrochloride
Fluoxifar
Fluoxil
Flutin
Flutine
Fluxen
Fluxene
Fluxil
Fondur
Fontex
Fonzac
Foxetin
Framex
FT-0626490
FT-0652216
GIYXAJPCNFJEHY-UHFFFAOYSA-N
HMS1569H03
HMS1922F07
HSDB 6633
HY-B0102A
I06-0079
I06-079
IN1336
J-521372
J10277
KM0299
KS-00000JJ6
KS-1061
Lilly 110140
Lorien
Lovan
LP00558
LS-185085
LS-31041
LS-7403
LY 110140
LY-110,140 hydrochloride
LY-110140
LY110140
Margrilan
methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine hydrochloride
Methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)ammonium chloride
MFCD00214288
Mitilase
MLS000069361
MLS001076338
MLS002222264
Modipran
MolPort-003-666-535
Motivone
Mutan
Mutin
N-METHYL-3-[(4-TRIFLUOROMETHYL)PHENOXY]-3-PHENYLPROPYLAMINE HYDROCHLORIDE
N-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride
N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine hydrochloride (1:1)
N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propylamine Hydrochloride
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride.
N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine Hydrochloride
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine hydrochloride
NC00715
NCGC00093943-01
NCGC00093943-02
NCGC00093943-03
NCGC00093943-04
NCGC00093943-05
NCGC00257736-01
NCGC00261243-01
Neupax
Nopres
NPL-2008
NSC-714457
NSC-758685
NSC714457
NSC758685
Nuzak
Nycoflox
Opera_ID_1538
Oxedep
Pharmakon1600-01504173
Pragmaten
Prestwick_798
Prizma
Proctin
Prodep
Profluzac
Propylamine, N-methyl-3-phenyl-3-(p-trifluoromethylphenoxy)-, hydrochloride
Prozac
Prozac (TN)
Prozac 20
Prozac Weekly
Prozac; LY-110,140 hydrochloride
Prozac;Sarafem
Psipax
Reconcile
RL04127
Rowexetina
s1333
SAM002589965
Sanzur
Sarafem
Saurat
SC-12129
SC-53387
SCHEMBL33384
Selfemra
Seronil
Sinzac
Siquial
SMR000058452
SPECTRUM1504173
SR-01000002988
SR-01000002988-2
SR-01000002988-4
SR-01000002988-9
ST24047216
SW196934-4
Tox21_200182
Tox21_500558
TRA-0205161
TRA0057937
TRA0075235
Tuneluz
Verotina
Z1741982921
Zactin
Zedprex
Zepax
Paragraph IV (Patent) Challenges for FLUOXETINE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
PROZAC SOLUTION;ORAL fluoxetine hydrochloride 020101
PROZAC TABLET;ORAL fluoxetine hydrochloride 020974
PROZAC CAPSULE;ORAL fluoxetine hydrochloride 018936
PROZAC WEEKLY CAPSULE, DELAYED REL PELLETS;ORAL fluoxetine hydrochloride 021235
SARAFEM CAPSULE;ORAL fluoxetine hydrochloride 018936

US Patents and Regulatory Information for fluoxetine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 074803-002 Jan 30, 2002 AB1 RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 078619-002 Jan 31, 2008 AB1 RX No No   Start Trial   Start Trial   Start Trial
Specgx Llc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075658-002 Jan 29, 2002 AB1 RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 211721-001 Jan 25, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Barr FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 075810-001 Feb 1, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Lupin Ltd FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 211653-001 Apr 15, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-002 Dec 24, 2003 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for fluoxetine hydrochloride

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Dow
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.